Stay updated on Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.

Latest updates to the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page
- Check5 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the revision tag updated to v3.6.0, with the older v3.5.5 removed. A recruitment status note No longer looking for participants appears, signaling termination due to low accrual.SummaryDifference0.5%

- Check12 days agoChange DetectedThe page revision tag was updated to v3.5.5, indicating a newer version of the page or site software. This change appears to be a maintenance update and does not modify the study details or other user-facing content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new page version. This change does not modify the study details or other content on the page.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s displayed “Revision” version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now displays Revision: v3.5.2, and the previous Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.